In hepatocellular carcinoma and glioblastoma, the role of METTL3 is unclear due to conflicting findings about whether the m6A methyltransferase complex promotes or inhibits cancer pathogenesis.8,41,42. The gene discussed is METTL3; the disease is cancer.